• Sonuç bulunamadı

Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome

N/A
N/A
Protected

Academic year: 2022

Share "Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome"

Copied!
7
0
0

Yükleniyor.... (view fulltext now)

Tam metin

Referanslar

Benzer Belgeler

Irritable Bowel Syndrome (IBS) is a functional bowel disease that causes complaints such as chronic recurrent abdominal pain, diarrhea, constipation and swelling in the abdomen and

Sonuç: İrritabl Bağırsak Sendromu hastalarının ilaç dışı yöntemleri kullanma oranlarının düşük olduğu, en çok bitkisel yöntemlerin kullanıldığı ayrıca hastaların

The State-Trait Anxiety Inventory (STAI); STAI-I was used to show patients' instant moods and STAI-II was used to show perpetual anxiety scales.. The State-Trait

[19] examined personality characteristics and quality of life in patients with functional gastrointestinal disorders and reported a type D person- ality rate of 37%.. [19]

Obez hastalarda sigara kullanımı ile İBS sıklığı arasında istatiksel olarak anlamlı ilişki saptanmıştır (p=0.003).. Buna karşılık cinsiyet, yaş, vücut kitle

Key words: atherosclerosis, autonomic dysfunction, arterial stiffness, carotid intima-media thickness, heart rate variability, irritable bowel syn- drome.. Murtaza Emre

Further inquiry into the possible causes of decreased intrathoracic impedance revealed that the patient had frequent episodes of irritable bowel syndrome, which

INTRODUCTION Given the limited data on autonomic dysfunction in patients with primary restless legs syndrome (pRLS), we compared autonomic dysfunction and presence of irritable